SLC7A5/LAT1 Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F3212-20UL

Regular price €95,00 EUR
Regular price Sale price €95,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

SLC7A5/LAT1 (Large Neutral Amino Acid Transporter 1), is a sodium- and pH-independent transmembrane transporter belonging to the SLC7 family within the APC superfamily. Structurally, it forms a heterodimeric complex with CD98 (SLC3A2) through a conserved disulfide bond, enabling the uptake of essential amino acids (e. g., leucine, phenylalanine) in exchange for intracellular amino acids like glutamine. Depending on the literature source, SLC7A5/LAT1 may also be discussed as SLC7A5/LAT1.

Reported cellular context includes apical cell membrane, cell membrane, and lysosome membrane, which can matter when signal is compared across treatments or changing cell states. Following SLC7A5/LAT1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

SLC7A5/LAT1 is commonly interpreted in the context of cancer, immunology, and metabolism research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans apical cell membrane, cell membrane, and lysosome membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between apical cell membrane, cell membrane, and lysosome membrane across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • context differences tied to immune-cell state, activation, or lineage composition
  • responses linked to nutrient status, mitochondrial state, or metabolic rewiring

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for SLC7A5/LAT1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in SLC7A5/LAT1 reflect biology rather than handling. When interpreting SLC7A5/LAT1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep SLC7A5/LAT1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
SLC7A5 • LAT1
Research Area:
Cancer • Immunology • Metabolism
Application:
FCM • IF • IHC • IP • WB
Reactivity:
Human
Specificity:
SLC7A5/LAT1 Antibody [N14A22] recognizes endogenous levels of total SLC7A5/LAT1 protein.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
N14A22
UniProt:
Q01650
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.